Acceleron Pharma
XLRN
#1573
Rank
ยฃ8.68 B
Marketcap
ยฃ141.97
Share price
0.00%
Change (1 day)
14,992.63%
Change (1 year)

Revenue for Acceleron Pharma (XLRN)

Revenue in 2021 (TTM): ยฃ82.64 Million

According to Acceleron Pharma's latest financial reports the company's current revenue is ยฃ89.56 Million. In 2020 the company made a revenue of ยฃ73.48 Million an increase over the revenue in the year 2019 that were of ยฃ58.76 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Acceleron Pharma from 2012 to 2021

Annual revenue

Year Revenue Change
2021 (TTM)ยฃ82.64 M12.46%
2020ยฃ73.48 M25.05%
2019ยฃ58.76 M428.85%
2018ยฃ11.11 M3.78%
2017ยฃ10.7 M-51.45%
2016ยฃ22.05 M53.47%
2015ยฃ14.37 M23.68%
2014ยฃ11.62 M-74.43%
2013ยฃ45.45 M275.17%
2012ยฃ12.11 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
ยฃ25.84 B 28,751.41%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ10.99 B 12,179.72%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ69.65 B 77,669.50%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ0.17 M-99.80%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ9.75 M-89.11%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ43.6 M-51.31%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ44.19 B 49,243.76%๐Ÿ‡บ๐Ÿ‡ธ USA